We are live on ! Find out more
GS

Gagnon Securities Portfolio holdings

AUM $519M
1-Year Est. Return 44.91%
This Fund
S&P 500
This Quarter Est. Return
+14.79%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$469M
AUM Growth
+$56M
Cap. Flow
+$14.2M
Cap. Flow %
3.02%
Top 10 Hldgs %
47.37%
Holding
102
New
11
Increased
30
Reduced
53
Closed
2
Avg Time Held Equity + Options
11.6 quarters
Top 10 Avg Time Held Equity + Options
8.2 quarters
Top 20 Avg Time Held Equity + Options
9.1 quarters
Avg Time Held Equity only
11.8 quarters
Top 10 Avg Time Held Equity only
8.2 quarters
Top 20 Avg Time Held Equity only
9.1 quarters

Top Buys

Rank Stock Value
1
BLFS icon
BioLife Solutions
BLFS
+$5.3M
2
CMLFU
CM Life Sciences, Inc. Unit
CMLFU
+$4.78M
3
MRK icon
Merck
MRK
+$4.12M
4
LL icon
LL Flooring Holdings, Inc.
LL
+$1.37M
5
PROF icon
Profound Medical
PROF
+$760K

Top Sells

Rank Stock Value
1
AMRC icon
Ameresco
AMRC
+$2.11M
2
CSLT
CASTLIGHT HEALTH, INC.
CSLT
+$1.3M
3
WPX
WPX Energy, Inc.
WPX
+$1.13M
4
ENSG icon
The Ensign Group
ENSG
+$569K
5
QDEL icon
QuidelOrtho
QDEL
+$563K

Sector Composition

Rank Sector Weight
1 Healthcare 36.82%
2 Technology 21.6%
3 Industrials 16.12%
4 Consumer Discretionary 11.14%
5 Energy 5.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CDNA icon
1
CareDx
CDNA
$3.47B
$41.1M 8.75%
1,082,043
-1,098
-0.1% -$37.1K
2014 Q3
24 quarters
AL icon
2
DELISTED
Air Lease Corp
AL
$26.6M 5.67%
903,102
+10,347
+1% +$305K
2013 Q2
29 quarters
PCRX icon
3
Pacira BioSciences
PCRX
$1.45B
$25.6M 5.46%
425,667
+3,526
+0.8% +$205K
2019 Q2
5 quarters
ENSG icon
4
The Ensign Group
ENSG
$10.1B
$23.5M 5%
411,281
-11,021
-3% -$569K
2018 Q2
9 quarters
AMRC icon
5
Ameresco
AMRC
$1.07B
$21.1M 4.5%
632,272
-69,795
-10% -$2.11M
2013 Q3
28 quarters
LL icon
6
DELISTED
LL Flooring Holdings, Inc.
LL
$20.3M 4.33%
921,544
+64,014
+7% +$1.37M
2015 Q1
22 quarters
FIVN icon
7
FIVE9
FIVN
$2.61B
$17.7M 3.78%
136,835
-2,076
-1% -$250K
2016 Q1
18 quarters
BL icon
8
BlackLine
BL
$1.71B
$16.3M 3.47%
181,780
-3,308
-2% -$278K
2018 Q3
8 quarters
ISRG icon
9
Intuitive Surgical
ISRG
$148B
$15.8M 3.38%
66,975
+375
+0.6% +$84.2K
2018 Q2
9 quarters
GFN
10
DELISTED
General Finance Corporation
GFN
$14.1M 3.01%
2,233,485
+115,843
+5% +$736K
2017 Q2
13 quarters
NVGS icon
11
Navigator Holdings
NVGS
$1.4B
$14M 2.99%
1,678,074
-26,987
-2% -$224K
2018 Q3
8 quarters
PROF icon
12
Profound Medical
PROF
$256M
$13.8M 2.93%
779,533
+47,818
+7% +$760K
2019 Q4
3 quarters
QDEL icon
13
QuidelOrtho
QDEL
$960M
$12.7M 2.7%
57,725
-2,522
-4% -$563K
2017 Q4
11 quarters
EQIX icon
14
Equinix
EQIX
$98.8B
$12.7M 2.7%
16,643
-103
-0.6% -$77.9K
2013 Q2
29 quarters
NEWR
15
DELISTED
New Relic, Inc.
NEWR
$11.9M 2.53%
210,635
-608
-0.3% -$37.1K
2016 Q3
16 quarters
EVBG icon
16
DELISTED
Everbridge, Inc. Common Stock
EVBG
$11.8M 2.51%
93,808
-854
-0.9% -$116K
2016 Q4
15 quarters
BLFS icon
17
DELISTED
BioLife Solutions
BLFS
$11.8M 2.51%
406,299
+245,223
+152% +$5.3M
2020 Q2
1 quarter
KMX icon
18
CarMax
KMX
$7B
$11M 2.34%
119,465
+6,293
+6% +$629K
2013 Q3
28 quarters
IRBT icon
19
DELISTED
iRobot
IRBT
$10.9M 2.32%
143,197
+2,808
+2% +$216K
2018 Q4
7 quarters
AOSL icon
20
Alpha and Omega Semiconductor
AOSL
$751M
$10.3M 2.2%
804,179
-1,590
-0.2% -$19.2K
2016 Q3
16 quarters
EPD icon
21
Enterprise Products Partners
EPD
$77.7B
$9.14M 1.95%
578,925
+18,442
+3% +$323K
2017 Q4
11 quarters
YEXT icon
22
Yext
YEXT
$689M
$8.54M 1.82%
562,897
+24,930
+5% +$421K
2019 Q1
6 quarters
PRLB icon
23
Protolabs
PRLB
$2.16B
$7.69M 1.64%
59,400
+2,913
+5% +$383K
2019 Q1
6 quarters
PNTG icon
24
Pennant Group
PNTG
$1.41B
$7.29M 1.55%
189,050
-24
-0% -$735
2019 Q4
3 quarters
CMG icon
25
Chipotle Mexican Grill
CMG
$38.1B
$6.08M 1.3%
244,300
+10,300
+4% +$248K
2016 Q1
18 quarters
1
2 3 4

Similar funds

WS
Wendel SE Paris $519M AUM 48.2% 1-Year Est. Return
MWC
MBM Wealth Consultants Chesterfield, Missouri $519M AUM 16.88% 1-Year Est. Return
MWM
Mindset Wealth Management Indianapolis, Indiana $519M AUM 46.03% 1-Year Est. Return
CFG
Compton Financial Group Towson, Maryland $519M AUM 14.76% 1-Year Est. Return
PDIP
Palo Duro Investment Partners Chicago, Illinois $518M AUM 22.62% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
SWM
Scissortail Wealth Management Tulsa, Oklahoma $520M AUM 21.73% 1-Year Est. Return

Gagnon Securities's Q3 2020 Portfolio in Review

As of Q3 2020, Gagnon Securities held 102 positions worth $469M, up 14% from $413M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Gagnon Securities deployed $14.2M of net new capital in Q3 2020, opening 11 new positions and adding to 30 existing holdings. Its largest new stake was CM Life Sciences, Inc. Unit: 454,204 shares worth $4.76M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Ameresco, an estimated $2.11M trimmed.

  • Gagnon Securities's largest Q3 2020 buy was CM Life Sciences, Inc. Unit: 454,204 shares worth $4.76M.
  • Gagnon Securities added most to BioLife Solutions in Q3 2020, an estimated $5.3M increase.
  • Gagnon Securities's biggest Q3 2020 reduction was Ameresco, cutting an estimated $2.11M.
  • Gagnon Securities fully exited Zogenix, Inc. in Q3 2020, selling an estimated $257K.
  • Gagnon Securities's ten largest holdings make up 47% of its $469M portfolio in Q3 2020.
  • Gagnon Securities opened 11 new positions and closed 2 in Q3 2020.
  • Gagnon Securities's portfolio value rose 14% quarter-over-quarter to $469M.

Based on Gagnon Securities's 13F filing for Q3 2020, filed 12 Nov 2020.